Ulrikka Nygaard

Ulrikka Nygaard serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Based at Blegdamsvej 3, 2200 Copenhagen N, she maintains active clinical and research roles with contact via Ulrikka.Nygaard@regionh.dk and +4535459761. Her work bridges pediatric infectious disease management and neurological outcomes through rigorous epidemiological frameworks.

Her research program centers on childhood infection trajectories, with emphasis on antibiotic optimization (particularly IV-to-oral transitions), neuroinfectious sequelae, and vaccine impact assessment. Key methodologies include nationwide Danish cohort analyses, register-based epidemiology, and translational biomarker studies. Current projects investigate long-term neurological outcomes after meningitis, fever pathophysiology in immunocompromised children, and real-world vaccine effectiveness.

Analysis of her 2025 publications reveals dominant themes in pediatric antimicrobial stewardship and post-infectious complications. Her cohort studies consistently leverage Denmark's comprehensive health registries to address clinically urgent questions about treatment safety and long-term outcomes. Notable trends include methodological innovation in non-inferiority trials for antibiotic administration and sophisticated tracking of neurological sequelae across multiple infection types.

Dr. Nygaard actively contributes to the Danish CHILD study group and collaborates extensively across national pediatric research networks. Her work garners significant attention, with recent publications covered by 18+ news outlets, discussed across 493+ X posts, and referenced in 652+ Bluesky discussions, reflecting substantial real-world impact on pediatric clinical practice guidelines.